Summary

Summary

Contract Unique IdentifierDO1.SLCNTR.496211 
Contract referenceInst. Nac. de Cancer-2020-01264 
Contract description:VARIOS MEDICAMENTOS 
Goods 
Contract Start:
04/01/2021 09:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End:
02/02/2021 09:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Legally Binding?
 
Contract StateModified 

Contracting Company Identification

Contracting Company Identification


Supplier Company Identification

Supplier Company Identification



Object Info

Object Info

DGCP-08-ProcesosExcepcion 
Inst. Nac. de Cancer-CCC-PEEX-2020-0078 
VARIOS MEDICAMENTOS 
VARIOS MEDICAMENTOS 
LOGISTICA 
DOCTORES MALLEN GUERRA-Inst. Nac. de Cancer-CCC-PE 
GoodsDominicana 
7,469,848.5 Dominican Pesos 

Financial & Delivery Conditions

Financial & Delivery Conditions

Delivery optionsTransporte incluido 
Contract Start Date
04/01/2021 09:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End Date
01/03/2021 09:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
nstituto Nacional del Cáncer Rosa Emilia Sánchez Pérez de Tavares Av. Correa y Cidrón, Esq. Rafael A. Sánchez Ravelo, Zona Universitaria DO 

Payment Conditions

Payment Conditions

Payment Method 
Invoice Payment Deadline60 days 

Contract Comments

Contract Comments


 
 
 1 
DO1.PCCNTR.1041635 ContractData Container
 1.1  
-
    
Total sin descuentosValor del descuentoTotal ITBISTotal Otros ImpuestosSubtotalTotal
7,469,848.500.000.000.005,429,555.007,469,848.50
    
ReferenciaCódigo UNSPSCCuenta presupuestariaDescripciónCantidadUnidadPrecio unitario estimadoPrecio unitarioImporte moneda orig. s/ITBIS% Desc.Descuento moneda originalMonto Gravado (Obras)% ITBISITBIS Moneda Original% Otros ImpuestosOtros impuestos moneda originalPrecio total estimadoValor del precio de respuesta
    
1
51111713 - Alemtuzumab
2.3.4.1.01BEVACIZUMAB 100 MG INY (AVASTIN)25UD24,80028,690717,250.000.000.000.00620,000.00717,250.00
    
2
51111713 - Alemtuzumab
2.3.4.1.01BEVACIZUMAB 400 MG INY (AVASTIN)20UD97,827114,7582,295,160.000.000.000.001,956,540.002,295,160.00
    
3
51111616 - Capecitabina
2.3.4.1.01CAPECITABINA 500 MG TABLETA (XELODA)3,000UD174180540,000.000.000.000.00522,000.00540,000.00
    
4
51111713 - Alemtuzumab
2.3.4.1.01CETUXIMAB 5 MG / 20 ML AMP (ERBITUX)30UD27,00030,215906,450.000.000.000.00810,000.00906,450.00
    
5
51151506 - Inhibidor de l(...)
2.3.4.1.01ERLOTINIB 150 MG COMP. (TARCEVA)15UD4,7105,310.779,660.500.000.000.0070,650.0079,660.50
    
6
51111718 - Valrubicina
2.3.4.1.01PERTUZUMAB 420 MG (PERJETA)3UD47,485246,452739,356.000.000.000.00142,455.00739,356.00
    
7
51111716 - Rituximab
2.3.4.1.01RITUXIMAB 1,400 MG / 11.7 ML INY (MABTHERA)7UD78,00078,400548,800.000.000.000.00546,000.00548,800.00
    
8
51111716 - Rituximab
2.3.4.1.01RITUXIMAB 500 MG INY (MABTHERA)10UD67,20067,200672,000.000.000.000.00672,000.00672,000.00
    
9
51111717 - Trastuzumab
2.3.4.1.01TRASTUZUMAB 600 MG / 5 ML VIAL (HERCEPTIN)9UD9,990107,908971,172.000.000.000.0089,910.00971,172.00
 
Contract Document Template

Contract Document Template

DescriptionFile Name
Download
Download
Download

Budget Settings

Budget Settings

Investment
General Source
9,605,110.00 DOP
 DOP
AccountValueAnnual Availability
2.3.4.1.019,605,110.00  DOP----View
Payment Calendar
IDDescriptionValueMonthYear
No items found...
Certificate of Appropriation
YearCertificate CodeCertificate VersionCertificate ValueCertificate StateCertificate Link
20200119,605,110.00  DOP